GI & Endoscopy

Samuel C. Somers, MD, is a gastroenterologist at Concord-based GI Associates of New Hampshire.

Here are five updates on gastroenterology and endoscopy companies.

A study in OncologyNurseAdvisor clarified the role of a nurse navigator during a colonoscopy screening.

Boston-based NinePoint Medical is benefiting from CMS' updated final fee schedule with its NvisionVLE Imaging System meeting criteria for a substantial increase in reimbursement.

New Haven, Conn.-based Alexion Pharmaceuticals has released data from studies related to the Phase 3 ARISE trial of Kanuma. Kanuma, or sebelipase alfa, is a drug treatment for lysosomal acid lipase deficiency.

New York-based Intercept Pharmaceuticals has released data from three studies related to the Phase 3 POISE trial of Ocaliva. The POISE trial tested daily Ocaliva treatment in patients with primary biliary cholangitis with an inadequate therapeutic response to ursodeoxycholic acid.

Richard Dumois, MD, is a gastroenterologist at Orlando, Fla.-based Central Florida Gastroenterology.

The Woodlands, Texas-based McKesson Specialty Health is launching its in-office dispensing solution in local rheumatology and gastroenterology practices.

Is the patient reported outcomes measurement information system implemented by the Bethesda, Md.-based National Institutes of Health producing better patient outcomes than traditional measures? A study in The American Journal of Gastroenterology found out.

As Rancho Santa Margarita, Calif-based Integrated Endoscopy prepares for the early 2017 launch of its single-use arthroscope, the company appointed several to its corporate leadership team.